VEN415

Clinical Research and Testing Site

Southwest US
 

The Company is an independent clinical research site. It provides exceptional expertise in an array of therapeutic areas of medicine as they relate to the research of drugs, vaccines, and medical devices.

Key Aspects:

  • Trait-searchable management database of over 22,000 potential subjects
  • Experienced Physicians in all aspects of clinical research
  • Licensed nurses and respiratory therapist with a minimum of seven years clinical research experience
  • Expanded Company budgets for current and upcoming studies that have been negotiated to an average of 22% above initial offers
  • Broad range of clinical indications with studies in pulmonary, allergy, internal medicine, vaccines, and devices
  • The reason for the decline in 2017 was the discontinuity of the allergic rhinitis research. In 2017, DXRG had multiple major projects get put on "hold", a usual industry occurrence, according to management

    Opportunities:

    • Hire dedicated business development specialist
    • Expand operations to add additional site locations and centralize business development
    • Explore additional studies regarding new pharmaceuticals and vaccines that are being developed
    • Increase subject base
       
       
       
      Year End 08/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
      YTD YTD YTD YTD YTD
      $'000 $'000 $'000 $'000 $'000
      Revenue 1,021 1,232 2,218 2,125 2,368
      Gross Profit 1,021 1,232 2,218 2,125 2,368
      Adj. EBITDA* 116 -73 246 0 183
      * Earnings before interest, tax, depreciation and amortization (non-cash items)
       
      Bids Invited